“…Other common markers include CD4, CD15, CD30, CD34, CD56, CD99, CD117, and Tdt; albeit our patient only expressed CD34, CD117, and Tdt . Expression of CD 117, a transmembrane protein receptor encoded by the c‐kit proto‐oncogene, has been associated with poorer outcomes . Immunohistochemistry for antimyeloperoxidase (MPO) has been shown to be the most useful and sensitive marker in differentiating between myeloid and nonmyeloid cells.…”